Positive Outcomes.
Positive Patient Stories.

Thomas J. Dietz, Ph.D
Thomas J. Dietz, Ph.D
Director

Thomas J. Dietz, Ph.D. has served on the Company’s Board of Directors since October 2014. Dr. Dietz has been Chairman and CEO of Waypoint Holdings, LLC, a diversified financial holdings and services company, since December 2010. Dr. Dietz was previously co-CEO and then CEO and a director of Pacific Growth Equities, LLC, an investment bank and institutional brokerage firm, from 2004 to January 2009, when the firm was acquired by Wedbush Securities, or Wedbush, a financial services firm. Dr. Dietz subsequently served as head of the investment banking division at Wedbush until November 2010. Dr. Dietz joined Pacific Growth in 1993 and served in various roles, including senior roles in equities research and investment banking, prior to taking the CEO role there. Dr. Dietz currently serves as Chairman on the board of directors of Eiger BioPharmaceuticals, Inc. (EIGR:Nasdaq) and as a Director of Leap Therapeutics, Inc. (LPTX:Nasdaq) in addition to several private companies. He previously served on the board of Transcept Pharmaceuticals, Inc. from April 2013 until its merger with Paratek on October 30, 2014. Previously, Dr. Dietz was a member of the research faculty in the Department of Medicine, University of California, San Francisco and the VA Medical Center. Dr. Dietz holds a Ph.D. in molecular biology and biochemistry from Washington University in St. Louis.

Join Our Team

Passion, accountability, and collaboration. At Paratek, we count on each other to build a company that saves lives. Learn more about life @Paratek.

Explore Careers

Our Stories

“I am inspired by the high-level of commitment demonstrated across the organization, to positively impact patient’s lives”

Glenn Cunningham, Regional Business Director

Our Stories

"I joined Paratek because of the people. I love their passion for our products."

Melanie Lauterio, Director, Medical Affairs

Our Stories

"Working on a product that has the potential to positively impact so many patient lives is very rewarding and gives me a great sense of purpose."

Stephen Viccica, Director, Regulatory Affairs

Our Stories

"Our culture is unique because we all come to Paratek with vast experience, and we work together to combine the decades of experience into one single purpose - to deliver NUZYRA to our patients."

Jen Schauble, Director, Supply Planning